| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 5, 2024 | Spero Therapeutics, Inc. | Chief Medical Officer | Sell | 91.3 | +211,656 | 36.72% | ✗ | $38.5K |
| Sep 13, 2023 | Sep 15, 2023 | Spero Therapeutics, Inc. | Chief Medical Officer | Sell | 42.5 | -39,496 | -6.41% | ✗ | $50.2K |